XABLECATH
XableCath is a medical device innovator, providing design leadership, industry expertise and resources to bring concepts to market as new products. Strong emphasis is placed on projects providing cost-effective treatment options for peripheral and cardiovascular disease states.
XABLECATH
Industry:
Health Care Manufacturing Medical Device
Founded:
2013-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.xablecath.com
Total Employee:
11+
Status:
Closed
Contact:
44 75 8713 2425
Email Addresses:
[email protected]
Total Funding:
1.17 M USD
Technology used in webpage:
IPhone / Mobile Compatible Google Font API Euro Amazon CloudFront OpenResty Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Adsense For Domains
Current Employees Featured
Founder
Investors List
Healthbox
Healthbox investment in Seed Round - XableCath
Official Site Inspections
http://www.xablecath.com
- Host name: 172.66.0.42
- IP address: 172.66.0.42
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "XableCath"
XableCath 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for XableCath. Use the PitchBook Platform to explore the full profile.See details»
XableCath - Funding, Financials, Valuation & Investors
A medical device innovator, providing design leadership, industry expertise and resources to bring concepts to market as new productsSee details»
Xablecath Inc Company Profile | Salt Lake City, UT | Competitors ...
Find company research, competitor information, contact details & financial data for Xablecath Inc of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»
XableCath - Contacts, Employees, Board Members, Advisors
XableCath has 2 current employee profiles, including Co-Founder, Chief Medical Officer and Scientific AdvisorJohannes Dahm.See details»
XableCath crossing catheters have received CE mark …
Feb 10, 2020 XableCath crossing catheter XableCath has announced that its XableCath Crossing catheters have received CE mark for peripheral use. Its crossing devices will be available for sale in Europe in two versions, a blunt tip …See details»
XableCath - Company Profile - Tracxn
Mar 11, 2025 XableCath - Over-the-wire catheter designed for facilitating guide wire and catheter access in peripheral and coronary lesions. This company is not active anymore. …See details»
XableCath, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore XableCath, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
FDA Clears XableCath Crossing Catheters - Endovascular Today
January 30, 2019—XableCath, Inc. announced that its XableCath blunt and abrasion tip catheters were cleared by the FDA as peripheral crossing catheters. XableCath is commencing a …See details»
XableCath wins CE Mark approval for crossing catheters
Mar 2, 2020 XableCath recently announced its Crossing Catheters received CE Mark approval for peripheral use. The crossing devices come in blunt tip and abrasion tip versions with a variety of diameters and lengths. The company …See details»
XableCathâ„¢ Receives CE Mark - Cardiac Vascular News
Feb 6, 2020 XableCathâ„¢, Inc., was founded in 2014 to commercialize catheters for the treatment of vascular disease. Its revolutionary technology allows effective peripheral …See details»
XableCath Crossing Catheters FDA Cleared - Cardiac Vascular News
SALT LAKE CITY, Jan. 30, 2019 (GLOBE NEWSWIRE) — XableCath, Inc., announced that its XableCathâ„¢ blunt and abrasion tip catheters, were cleared by the FDA as Peripheral Crossing …See details»
XableCath Scores FDA Clearance for Broadly Effective Catheter
Dec 18, 2017 XableCath President and CEO, Lisa Dunlea commented, “Different from most interventional devices used to facilitate lesion passage, XableCath was designed to be one of …See details»
XableCath crossing catheters have received CE mark for peripheral …
Feb 10, 2020 XableCath crossing catheter XableCath has announced that its XableCath Crossing catheters have received CE mark for peripheral use. Its crossing devices will be …See details»
XableCath Crossing Catheters FDA Cleared - GlobeNewswire
Jan 30, 2019 About XableCath XableCath was founded in 2014 to commercialize catheters for the treatment of vascular disease.See details»
PAD catheter effective in all lesion types receives FDA clearance
Jan 10, 2018 XableCath has received US FDA clearance for its blunt tip catheter, which despite being developed for the peripheral arterial disease (PAD) market has proven effective in all …See details»
XableCath Receives FDA Clearance for Broadly Effective Catheter …
Dec 18, 2017 XableCath announced its blunt tip support catheter has received clearance from the FDA for use in treating peripheral arterial disease.See details»
FDA Clears XableCath Catheter for Peripheral Arterial Disease
The XableCath blunt-tip catheter is unique in its ability to cross chronic total occlusions quickly while remaining over-the-wire and in the true lumen. XableCath catheters will be powerful tools …See details»
FDA Approves Catheter for Use in PAD
The XableCath blunt tip support catheter has been approved by the US Food and Drug Administration (FDA). The catheter is indicated for treatment of peripheral arterial disease …See details»
XableCath gets US FDA clearance for broadly effective catheter …
Dec 19, 2017 XableCath has announced its XableCath blunt tip support catheter has received clearance from the US FDA. The blunt tip catheter facilitates true lumen passage of lesions, …See details»